Oral contraceptives containing oestrogen and progestagen in high dosage may produce many undesirable side effects. The risk of thrombo-phlebotic episodes (Vessey & Doll, 1969) has caused much concern, but the possible long-term effects of the numerous metabolic changes have also to be considered. Amongst the latter, impaired glucose tolerance (Wynn & Doar, 1969) and increased levels of serum glutamic\p=m-\pyruvate transaminase (SGPT) have been reported (Larsson-Cohn, 1965) .
Oral glucose tolerance tests (GTT) were carried out on 103 women (aged 17 to 47) who had been on a regimen of oral contraception with 50 \ g=m\ g norgestrel/day for over a year. After a fast from 22.00 hours on the previous night, initial specimens of venous blood were taken, followed by the loading dose of 50 g glucose in 100 ml water. Subsequent venous samples were collected after \, 1 (Clinch, Turnbull & Khosla, 1969 
